"HIV治療" の関連情報検索結果
A Potential Cure for AIDS: Defeating HIV With a Single Injection - SciTechDaily

A Potential Cure for AIDS: Defeating HIV With a Single Injection SciTechDaily
Can babies infected with HIV be cured? New study offers cautious optimism - Science | AAAS

Can babies infected with HIV be cured? New study offers cautious optimism Science | AAAS
Some children who start antiretrovirals very early may control HIV after stopping treatment - Aid...

Some children who start antiretrovirals very early may control HIV after stopping treatment Aidsmap
HIV positive sperm bank launched in New Zealand - News-Medical

HIV positive sperm bank launched in New Zealand News-Medical
WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls World Health Organization (WHO)
Monthly HIV injection could free patients from gruelling drug regimen - Nature

Monthly HIV injection could free patients from gruelling drug regimen Nature
Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-...

Merck's HIV treatment meets main goal in two late-stage studies - Reuters

Merck's HIV treatment meets main goal in two late-stage studies Reuters
Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies - Fier...

Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies Fierce Biotech
Will post-treatment controllers guide us towards an HIV cure? - Aidsmap

Will post-treatment controllers guide us towards an HIV cure? Aidsmap
HIV services in Ukraine resilient but starting to feel the strain - Aidsmap

HIV services in Ukraine resilient but starting to feel the strain Aidsmap
So far, Poland has seen fewer Ukrainian refugees with HIV than expected - Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected Aidsmap
Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment - Aid...

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment Aidsmap
Further evidence that recycling tenofovir in second-line treatment is effective - Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective Aidsmap
London patient in long-term HIV remission after stem cell transplant - Aidsmap

London patient in long-term HIV remission after stem cell transplant Aidsmap
After viral rebound, dolutegravir-based treatment more likely to suppress HIV - Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV Aidsmap
People-centred blood pressure management improves blood pressure in people with HIV - Aidsmap

People-centred blood pressure management improves blood pressure in people with HIV Aidsmap
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds Aidsmap
Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...

What are the roles of TAF and integrase inhibitors in weight gain? - Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain? Aidsmap
Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...

Islatravir plus doravirine remains effective at 96 weeks - Aidsmap

Islatravir plus doravirine remains effective at 96 weeks Aidsmap
Dolutegravir recommended for all in new World Health Organization guidelines - Aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines Aidsmap
SEARCH study finds universal 'test and treat' reduces infant HIV - Aidsmap

SEARCH study finds universal 'test and treat' reduces infant HIV Aidsmap
Infected blood: Devon mum not told for three years of son's HIV - BBC

Infected blood: Devon mum not told for three years of son's HIV BBC
Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment Aidsmap
Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - Aid...

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries Aidsmap
South Africa: dropping out of HIV care is deadly - Aidsmap

South Africa saves $326 million on dolutegravir - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe Aidsmap
Oral six-month treatment for MDR-TB is safe and effective in people with HIV - Aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV Aidsmap
How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day - Quartz

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day Quartz
Genetically engineered white blood cells could be the future of HIV treatment - The Verge

Genetically engineered white blood cells could be the future of HIV treatment The Verge
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - Aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women Aidsmap
Are CD4 counts still useful in the 'treat all' era? - Aidsmap

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir...

ADVANCE trial shows dolutegravir is highly effective in South Africa - Aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa Aidsmap
Figure 2. The T cell response to HIV infection, tumor immune evasion in... - ResearchGate

Figure 2. The T cell response to HIV infection, tumor immune evasion in... ResearchGate
Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) Aidsmap
Myanmar on brink of HIV treatment crisis - Frontier Myanmar

Myanmar on brink of HIV treatment crisis Frontier Myanmar
(PDF) Understanding the role of social workers in the promotion and uptake of prevention of mothe...

Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter...

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) Aidsmap